Note: VBI Vaccines's revenues are gauged from an analysis of company filings.
VBI Vaccines has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
June 22, 2020
Complete list of funding rounds and total amounts in the Company Report
Determine whether VBI Vaccines grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof VBI Vaccines is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of VBI Vaccines's Largest Competitors
A competitive analysis shows these companies are in the same general field as VBI Vaccines, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to VBI Vaccines.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as VBI Vaccines and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.